Hoth Therapeutics (HOTH) announced “promising” findings for its novel therapeutic candidate, HT-001, a topical neurokinin 1 receptor antagonist, in the treatment of Epidermal Growth Factor ...

(PRNewsfoto/Hoth Therapeutics Inc.) "These compelling findings reinforce GDNF's potential to fundamentally alter the way we approach obesity treatment," said Robb Knie CEO of Hoth Therapeutics.

Atour Lifestyle Holdings (ATAT) is advancing 3% after Citi raised its price target on the shares to $35.80 from $30.50. The bank kept a Buy rating on the stock. ATAT is a China-based hotel chain ...

(RTTNews) - Hoth Therapeutics (HOTH) announced preclinical findings that highlight the potential of Glial Cell Line-Derived Neurotrophic Factor as a treatment for obesity. The study, conducted in ...

Atour Lifestyle Holdings (ATAT) is advancing 3% after Citi raised its price target on the shares to $35.80 from $30.50. The bank kept a Buy rating on the stock. ATAT is a China-based hotel chain that ...

In this article, we are going to take a look at where Atour Lifestyle Holdings Limited (NASDAQ:ATAT) stands against other best young stocks to buy and hold for 10 years. On January 29, Martín ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

French startup Flying Whales is on a mission to transform cargo transport with its ambitious Large Capacity Airship 60 Tonne (LCA60T) project. This colossal helium-filled airship, measuring 656 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...